These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 20064477)
1. Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis. Yan W; Faisal SM; McDonough SP; Chang CF; Pan MJ; Akey B; Chang YF Vaccine; 2010 Mar; 28(11):2277-83. PubMed ID: 20064477 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates. Chang YF; Chen CS; Palaniappan RU; He H; McDonough SP; Barr SC; Yan W; Faisal SM; Pan MJ; Chang CF Vaccine; 2007 Nov; 25(48):8190-7. PubMed ID: 17936448 [TBL] [Abstract][Full Text] [Related]
3. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Faisal SM; Yan W; McDonough SP; Chang YF Vaccine; 2009 Jan; 27(3):378-87. PubMed ID: 19022317 [TBL] [Abstract][Full Text] [Related]
4. Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis. Faisal SM; Yan W; McDonough SP; Mohammed HO; Divers TJ; Chang YF Vaccine; 2009 Oct; 27(44):6129-36. PubMed ID: 19715780 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Faisal SM; Yan W; Chen CS; Palaniappan RU; McDonough SP; Chang YF Vaccine; 2008 Jan; 26(2):277-87. PubMed ID: 18055070 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model. Cao Y; Faisal SM; Yan W; Chang YC; McDonough SP; Zhang N; Akey BL; Chang YF Vaccine; 2011 Oct; 29(43):7379-86. PubMed ID: 21803087 [TBL] [Abstract][Full Text] [Related]
7. Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model. Faisal SM; Yan W; McDonough SP; Chang CF; Pan MJ; Chang YF Vaccine; 2009 Nov; 27(47):6537-45. PubMed ID: 19729088 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Yan W; Faisal SM; McDonough SP; Divers TJ; Barr SC; Chang CF; Pan MJ; Chang YF Microbes Infect; 2009 Feb; 11(2):230-7. PubMed ID: 19070678 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis. Seixas FK; Fernandes CH; Hartwig DD; Conceição FR; Aleixo JA; Dellagostin OA Can J Microbiol; 2007 Apr; 53(4):472-9. PubMed ID: 17612601 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Immunoprotection of Leptospira Recombinant Proteins with conventional vaccine in experimental animals. Parthiban M; Kumar SS; Balachandran C; Kumanan K; Aarthi KS; Nireesha G Indian J Exp Biol; 2015 Dec; 53(12):779-85. PubMed ID: 26742322 [TBL] [Abstract][Full Text] [Related]
12. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Lucas DS; Cullen PA; Lo M; Srikram A; Sermswan RW; Adler B Vaccine; 2011 Apr; 29(18):3413-8. PubMed ID: 21396409 [TBL] [Abstract][Full Text] [Related]
13. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Seixas FK; da Silva EF; Hartwig DD; Cerqueira GM; Amaral M; Fagundes MQ; Dossa RG; Dellagostin OA Vaccine; 2007 Dec; 26(1):88-95. PubMed ID: 18063449 [TBL] [Abstract][Full Text] [Related]
14. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Palaniappan RU; McDonough SP; Divers TJ; Chen CS; Pan MJ; Matsumoto M; Chang YF Infect Immun; 2006 Mar; 74(3):1745-50. PubMed ID: 16495547 [TBL] [Abstract][Full Text] [Related]
15. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. Yang HL; Zhu YZ; Qin JH; He P; Jiang XC; Zhao GP; Guo XK BMC Genomics; 2006 Nov; 7():293. PubMed ID: 17109759 [TBL] [Abstract][Full Text] [Related]
16. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. Gamberini M; Gómez RM; Atzingen MV; Martins EA; Vasconcellos SA; Romero EC; Leite LC; Ho PL; Nascimento AL FEMS Microbiol Lett; 2005 Mar; 244(2):305-13. PubMed ID: 15766783 [TBL] [Abstract][Full Text] [Related]
17. [Solubilization of components of outer membrane of Leptospira interrogans serovar mozdok by sodium desoxycholate and triton X-100 and evaluation of their immunogenic capacity and homologous and heterologous protection induced in hamsters]. Rivera YF; Navarro YP; Mazorra YA; Rodríguez AG; Padrón Mde L; Valdés Y Rev Cubana Med Trop; 2005; 57(1):53-4. PubMed ID: 17966480 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters. Humphryes PC; Weeks ME; AbuOun M; Thomson G; Núñez A; Coldham NG Clin Vaccine Immunol; 2014 Apr; 21(4):546-51. PubMed ID: 24521782 [TBL] [Abstract][Full Text] [Related]
19. Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs. Lin X; Xiao G; Luo D; Kong L; Chen X; Sun D; Yan J BMC Microbiol; 2016 Oct; 16(1):241. PubMed ID: 27737644 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation. Murray GL; Lo M; Bulach DM; Srikram A; Seemann T; Quinsey NS; Sermswan RW; Allen A; Adler B Vaccine; 2013 Jan; 31(3):495-9. PubMed ID: 23176980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]